Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pincus

Showing results (201-210 of 216) with videos related to

Pageof 22
Sort By:
The EMBO Journal|March 4, 1999
Regulation of JNK signaling by GSTpV Adler, Z Yin, S Y Fuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranesEhsan Sarafraz-Yazdi, Wilbur B Bowne, Victor Adler, et al.
Annals of Clinical and Laboratory Science|December 15, 2015
Ex vivo Efficacy of Anti-Cancer Drug PNC-27 in the Treatment of Patient-Derived Epithelial Ovarian CancerEhsan Sarafraz-Yazdi, Constantine Gorelick, Allison R Wagreich, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cellsM Kanovsky, A Raffo, L Drew, et al.
Annals of Clinical and Laboratory Science|August 1, 2025
HDM-2-Targeting Peptide PNC-27 Kills Cervical Cancer Cells but not Normal Cervical CellsPatryck K Krzesaj, Shabnam Seydafkan, Anna I Miller, et al.
Biomedicines|May 28, 2022
PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell LysisEhsan Sarafraz-Yazdi, Stephen Mumin, Diana Cheung, et al.
American Journal of Cancer Research|June 25, 2014
Imbalanced expression of Tif1γ inhibits pancreatic ductal epithelial cell growthMartin Ligr, Xinyu Wu, Garrett Daniels, et al.
Anticancer Research|September 4, 2020
Targeting Membrane HDM-2 by PNC-27 Induces Necrosis in Leukemia Cells But Not in Normal Hematopoietic CellsAnusha Thadi, Lauren Lewis, Eve Goldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Conformation-dependent phosphorylation of p53V Adler, M R Pincus, T Minamoto, et al.
Oncogene|March 12, 2003
Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding siteTamara N Do, Ramon V Rosal, Lisa Drew, et al.
Pageof 22

Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
The EMBO Journal|March 4, 1999
Regulation of JNK signaling by GSTpV Adler, Z Yin, S Y Fuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranesEhsan Sarafraz-Yazdi, Wilbur B Bowne, Victor Adler, et al.
Annals of Clinical and Laboratory Science|December 15, 2015
Ex vivo Efficacy of Anti-Cancer Drug PNC-27 in the Treatment of Patient-Derived Epithelial Ovarian CancerEhsan Sarafraz-Yazdi, Constantine Gorelick, Allison R Wagreich, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cellsM Kanovsky, A Raffo, L Drew, et al.
Annals of Clinical and Laboratory Science|August 1, 2025
HDM-2-Targeting Peptide PNC-27 Kills Cervical Cancer Cells but not Normal Cervical CellsPatryck K Krzesaj, Shabnam Seydafkan, Anna I Miller, et al.
Biomedicines|May 28, 2022
PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell LysisEhsan Sarafraz-Yazdi, Stephen Mumin, Diana Cheung, et al.
American Journal of Cancer Research|June 25, 2014
Imbalanced expression of Tif1γ inhibits pancreatic ductal epithelial cell growthMartin Ligr, Xinyu Wu, Garrett Daniels, et al.
Anticancer Research|September 4, 2020
Targeting Membrane HDM-2 by PNC-27 Induces Necrosis in Leukemia Cells But Not in Normal Hematopoietic CellsAnusha Thadi, Lauren Lewis, Eve Goldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Conformation-dependent phosphorylation of p53V Adler, M R Pincus, T Minamoto, et al.
Oncogene|March 12, 2003
Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding siteTamara N Do, Ramon V Rosal, Lisa Drew, et al.
Pageof 22